Clinical Trial Results:
A 2-year randomized, multicenter, double-blind, placebocontrolled
study to determine the efficacy and safety of
intravenous zoledronic acid 5 mg administered either
annually at randomization and 12 months, or administered
at randomization only in the prevention of bone loss in
postmenopausal women with osteopenia
Summary
|
|
EudraCT number |
2004-000638-35 |
Trial protocol |
SE ES |
Global completion date |
15 Feb 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Apr 2016
|
First version publication date |
20 Apr 2016
|
Other versions |
|
Summary report(s) |
CZOL446N2312 CT.gov results public |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.